Emily Kowalski

DMARD disruption, rheumatic disease flare, and prolonged COVID-19 symptom duration after acute COVID-19 among patients with rheumatic disease: A prospective study

Michael Di Iorio, Claire Cook, Kathleen M.M. Vanni et al. · Seminars in Arthritis and Rheumatism · 2022 · 66 citations · Full text

Medicine, Immunology, Internal Medicine +14

SARS-CoV-2 breakthrough infections among vaccinated individuals with rheumatic disease: results from the COVID-19 Global Rheumatology Alliance provider registry

Jean W. Liew, Milena Gianfrancesco, Carly Harrison et al. · RMD Open · 2022 · 51 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +13

Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: a retrospective cohort study

Grace Qian, Xiaosong Wang, Naomi J. Patel et al. · The Lancet Rheumatology · 2023 · 49 citations · Full text

Life Sciences, Immunology, Internal Medicine +15

Factors associated with COVID-19 breakthrough infection among vaccinated patients with rheumatic diseases: A cohort study

Naomi J. Patel, Xiaosong Wang, Xiaoqing Fu et al. · Seminars in Arthritis and Rheumatism · 2022 · 48 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +12

Risk of severe COVID-19 outcomes associated with rheumatoid arthritis and phenotypic subgroups: a retrospective, comparative, multicentre cohort study

Gabriel Figueroa‐Parra, Emily Gilbert, Maria O Valenzuela-Almada et al. · The Lancet Rheumatology · 2022 · 46 citations · Full text

Life Sciences, Health Sciences, Immunology +11